SAN FRANCISCO, Nov. 2, 2016 /PRNewswire/ -- Symic Bio, a clinical-stage biopharmaceutical company developing a new category of therapeutics focused on extracellular matrix biology, today announced that Rinko Ghosh, President and Chief Business Officer, will present at the 22nd Annual BIO Europe Conference in Cologne. The presentation will take place within the autoimmune/inflammation track.
Conference details are as follows:
Date: Tuesday, Nov. 8, 2016
Time: 3:00 p.m. CET
Location: Rheinsaal 4, Level 2, Koelnmesse - Congress Center North, Cologne, Germany